Work

A phase 1 first-in-human study of the novel anti-LLT1 antibody (ZM008) alone and in combination with anti-PD1 antibody in patients with advanced solid tumors.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps2688

Authors: Maloy Ghosh, Jyotsna Fuloria, Ignacio Garcia-Ribas, Ildefonso Ismael Rodriguez Rivera, Andrae Lavon Vandross, Glenn J. Hanna, Anurag Tiwari, Ashvini Kumar Dubey, Sanghamitra Bhattacharjee, Yogendra Manjunath, Shalini Kashipathi Sureshbabu

Institutions: Texas Oncology, Dana-Farber Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410810026

FWCI:

Cites:

Cited by:

Related to: 10